• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Automated Cell Culture Equipment Market Research Report - Forecast till 2032 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Automated Cell Culture Equipment Market

    ID: MRFR/MED/7298-CR
    115 Pages
    Kinjoll Dey
    February 2020

    Automated Cell Culture Equipment Market Research Report Information by Lab Automation Type (Modular Automation and Whole Lab Automation), by Product Type (Consumables, Equipment and Software), Application (Biopharmaceutical Production, Tissue Engineering, Vaccine Production, Gene Therapy & Regenerative Medicine, Stem Cell Therapy, Toxicity Testing and Diagnostics), End User (Pharmaceutical & Biotechnology Companies, Research and Academic Institutes and Hospitals and Diagnostic Laboratories) - Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Automated Cell Culture Equipment Market Research Report - Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Automated Cell Culture Equipment Market Summary

    The Global Automated Cell Culture Equipment Market is projected to grow from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Automated Cell Culture Equipment Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate (CAGR) of 7.37% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 2.12 USD Billion, indicating substantial growth potential.
    • In 2024, the market is valued at 0.97 USD Billion, laying a solid foundation for future expansion.
    • Growing adoption of automated cell culture technologies due to increased demand for high-throughput screening is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.97 (USD Billion)
    2035 Market Size 2.12 (USD Billion)
    CAGR (2025-2035) 7.37%

    Major Players

    Tecan Trading AG, Siemens, Pfizer Inc., Hitachi, Ltd, Thermo Fisher Scientific Inc., Sartorius AG, Hamilton Company, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Perkinelmer, Inc., Anton Paar GmBH, Becton, Dickinson, and Company (U.S.), HiMedia Laboratories (India), GE Healthcare (U.S.), Lonza (Switzerland), CellGenix GmbH (Germany)

    Automated Cell Culture Equipment Market Trends

    The increasing demand for advanced biopharmaceuticals and regenerative medicine is driving innovation in automated cell culture technologies, which are poised to enhance research efficiency and reproducibility.

    U.S. National Institutes of Health (NIH)

    Automated Cell Culture Equipment Market Drivers

    Market Growth Projections

    The Global Automated Cell Culture Equipment Market Industry is projected to experience substantial growth over the coming years. The market is expected to reach approximately 0.97 USD Billion in 2024 and is forecasted to grow to around 2.12 USD Billion by 2035. This growth trajectory suggests a robust demand for automated solutions in cell culture processes. The anticipated CAGR of 7.37% from 2025 to 2035 indicates a strong market potential, driven by various factors including technological advancements, increased investment in R&D, and a rising focus on personalized medicine. This upward trend highlights the importance of automated cell culture equipment in modern biopharmaceutical development.

    Rising Demand for Biopharmaceuticals

    The Global Automated Cell Culture Equipment Market Industry experiences a notable surge in demand driven by the increasing need for biopharmaceuticals. As the global population ages and chronic diseases rise, the biopharmaceutical sector is expected to expand significantly. In 2024, the market is valued at approximately 0.97 USD Billion, reflecting the industry's growth potential. This trend is likely to continue, with projections indicating a market size of 2.12 USD Billion by 2035. The CAGR of 7.37% from 2025 to 2035 suggests that automated cell culture equipment will play a crucial role in meeting the production demands of biopharmaceuticals.

    Increased Focus on Personalized Medicine

    The Global Automated Cell Culture Equipment Market Industry is significantly influenced by the growing emphasis on personalized medicine. As healthcare shifts towards tailored therapies, the demand for advanced cell culture techniques rises. Automated cell culture systems facilitate the development of patient-specific treatments by enabling high-throughput screening and efficient cell manipulation. This trend is expected to contribute to the market's expansion, with a projected growth from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035. The CAGR of 7.37% from 2025 to 2035 indicates that automated cell culture equipment will be integral to the future of personalized medicine.

    Technological Advancements in Automation

    Technological advancements in automation are pivotal for the Global Automated Cell Culture Equipment Market Industry. Innovations such as robotics, artificial intelligence, and machine learning enhance the efficiency and precision of cell culture processes. These technologies streamline workflows, reduce human error, and improve reproducibility, which are essential for research and production. As laboratories increasingly adopt automated solutions, the market is poised for growth. The anticipated increase in market size from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035 underscores the importance of these advancements in driving the adoption of automated cell culture equipment.

    Growing Investment in Research and Development

    Investment in research and development is a critical driver for the Global Automated Cell Culture Equipment Market Industry. As organizations strive to innovate and develop new therapies, the demand for sophisticated cell culture systems increases. Enhanced funding from both public and private sectors supports the development of automated solutions that improve research outcomes. The market's growth from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035 reflects this trend. The projected CAGR of 7.37% from 2025 to 2035 indicates that sustained investment in R&D will likely propel the adoption of automated cell culture equipment.

    Regulatory Support for Advanced Cell Culture Techniques

    Regulatory bodies are increasingly supporting the adoption of advanced cell culture techniques, which positively impacts the Global Automated Cell Culture Equipment Market Industry. Guidelines that promote the use of automated systems in research and production enhance compliance and safety in biopharmaceutical manufacturing. This regulatory support encourages investment in automated technologies, leading to market growth. With the market projected to grow from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035, the role of regulatory frameworks in facilitating the adoption of automated cell culture equipment cannot be understated. The anticipated CAGR of 7.37% from 2025 to 2035 further emphasizes this trend.

    Market Segment Insights

    Regional Insights

    Key Companies in the Automated Cell Culture Equipment Market market include

    Industry Developments

    Various developments are seen in the automated cell culture equipment market which is as follows:

      • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
      • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
      • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
      • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
      • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 

    Future Outlook

    Automated Cell Culture Equipment Market Future Outlook

    The Automated Cell Culture Equipment Market is projected to grow at a 7.37% CAGR from 2024 to 2035, driven by technological advancements, increasing demand for biopharmaceuticals, and enhanced research capabilities.

    New opportunities lie in:

    • Develop automated systems for personalized medicine applications.
    • Invest in AI-driven analytics for optimized cell culture processes.
    • Expand product lines to include sustainable and eco-friendly materials.

    By 2035, the market is expected to achieve substantial growth, reflecting advancements and increased adoption across various sectors.

    Market Segmentation

    Report Overview

    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Regional Analysis

    • CellGenix GmbH (Germany).
    • Lonza (Switzerland)
    • GE Healthcare (U.S.)
    • HiMedia Laboratories (India)
    • Anton Paar GmBH . Becton, Dickinson, and Company (U.S.)
    • Perkinelmer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Beckman Coulter, Inc.
    • Hamilton Company
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Hitachi, Ltd
    • Pfizer Inc.
    • Siemens
    • Tecan Trading AG
    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Recent Development

    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Competitive Landscape

    • CellGenix GmbH (Germany).
    • Lonza (Switzerland)
    • GE Healthcare (U.S.)
    • HiMedia Laboratories (India)
    • Anton Paar GmBH . Becton, Dickinson, and Company (U.S.)
    • Perkinelmer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Beckman Coulter, Inc.
    • Hamilton Company
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Hitachi, Ltd
    • Pfizer Inc.
    • Siemens
    • Tecan Trading AG
    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Automated Cell Culture Equipment Market on end-user

    • CellGenix GmbH (Germany).
    • Lonza (Switzerland)
    • GE Healthcare (U.S.)
    • HiMedia Laboratories (India)
    • Anton Paar GmBH . Becton, Dickinson, and Company (U.S.)
    • Perkinelmer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Beckman Coulter, Inc.
    • Hamilton Company
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Hitachi, Ltd
    • Pfizer Inc.
    • Siemens
    • Tecan Trading AG
    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 0.90 (USD Billion)
    Market Size 2024 0.97 (USD Billion)
    Market Size 2032 1.71 (USD Billion)
    Compound Annual Growth Rate (CAGR) 7.43 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Tecan Trading AG, Hamilton Company, Beckman Coulter, Inc., Pfizer Inc., Hitachi, Ltd, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Anton Paar GmBH, Sartorius AG, Perkinelmer, Inc., and Siemens
      Key Market Opportunities   Growing research & development (R&D) initiatives in the pharmaceutical industry
      Key Market Drivers ·  The rising prevalence of cancer and other chronic disorders demands the discovery of newer and more effective drugs for their treatment. ·  The growing incidence of cancer and other chronic diseases is anticipated to fuel the market growth

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Get In Touch
    Leave a Comment

    FAQs

    What is the projected market value of the automated cell culture equipment market?

    Automated cell culture equipment market is touted to record a substantial market valuation of USD 1.71 Billion by 2032.

    What is the estimated growth rate of the automated cell culture equipment market?

    Automated cell culture equipment market is projected to register a moderate 7.43% CAGR in the forecast period.

    Which factors are poised to drive the automated cell culture equipment market growth?

    The massive growth of the automated cell culture equipment market is driven by the growing R&D projects in the pharmaceutical industry.

    Which type is touted to witness the highest growth?

    The modular automation segment is expected to observe substantial demand over the review period.

    Which region is expected to observe the highest growth?

    The APAC is poised to secure the highest CAGR.

    What is the application of the automated cell culture equipment market expected to witness the highest growth?

    The stem cell therapy segment is slated to mature as the fastest-growing segment.

    Who are the significant players operative in the automated cell culture equipment market?

    A few eminent market players functioning in the global automated cell culture equipment market are Siemens, Pfizer Inc., Thermo Fisher Scientific Inc., Hitachi, Ltd, among others.

    1. Executive Summary
      1. MARKET SYNOPSIS 18
    2. Market Introduction
      1. DEFINITION 19
      2. SCOPE OF THE STUDY 19
      3. RESEARCH OBJECTIVE 19
      4. MARKET STRUCTURE 20
    3. Research Methodology
      1. RESEARCH PROCESS
      2. PRIMARY RESEARCH 22
      3. SECONDARY RESEARCH 23
      4. MARKET SIZE
    4. ESTIMATION 23
      1. FORECAST MODEL 25
      2. LIST OF ASSUMPTIONS 26
    5. MARKET DYNAMICS
      1. OVERVIEW 27
      2. DRIVERS 28
        1. GROWING RESEARCH
    6. AND DEVELOPMENT INITIATIVES IN THE PHARMACEUTICAL INDUSTRY 28
      1. RISE IN
    7. ADOPTION OF LIQUID HANDLING SYSTEMS 28
      1. INCREASING PREVALENCE OF CANCER
    8. AND OTHER CHRONIC DISEASES 29
      1. RESTRAINTS 30
        1. HIGH MAINTAINANCE
    9. COST 30
      1. OPPORTUNITIES 31
        1. RISING FOCUS ON REGENERATIVE MEDICINE
    10. MARKET FACTOR ANALYSIS
      1. PORTER’S FIVE FORCES MODEL 32
        1. BARGAINING POWER OF SUPPLIERS 33
        2. BARGAINING POWER OF BUYERS 33
        3. THREAT OF NEW ENTRANTS 33
        4. THREAT OF SUBSTITUTES 33
    11. INTENSITY OF RIVALRY 33
      1. VALUE CHAIN ANALYSIS 34
        1. R&D AND
    12. DESIGNING 35
      1. MANUFACTURING 35
        1. DISTRIBUTION & SALES 35
        2. POST-SALES MONITORING 35
    13. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
    14. BY LAB AUTOMATION TYPE
      1. OVERVIEW 36
      2. MODULAR AUTOMATION 38
    15. WHOLE LAB AUTOMATION 38
    16. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT
    17. TYPE
      1. OVERVIEW 39
      2. CONSUMABLES 42
      3. EQUIPMENT 42
    18. SOFTWARE 43
    19. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    20. OVERVIEW 44
      1. BIOPHARMACEUTICAL PRODUCTION 46
      2. TISSUE ENGINEERING
      3. VACCINE PRODUCTION 47
      4. DRUG SCREENING AND DEVELOPMENT 48
      5. GENE THERAPY & REGENERATIVE MEDICINE 48
      6. STEM CELL THERAPY 49
      7. TOXICITY TESTING 49
      8. DIAGNOSTICS 50
    21. GLOBAL AUTOMATED CELL CULTURE
    22. EQUIPMENT MARKET, END USER
      1. OVERVIEW 51
      2. PHARMACEUTICAL & BIOTECHNOLOGY
    23. COMPANIES 53
      1. RESEARCH AND ACADEMIC INSTITUTES 53
      2. HOSPITALS AND
    24. DIAGNOSTIC LABORATORIES 54
    25. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET,
    26. BY REGION
      1. OVERVIEW 55
      2. AMERICAS 57
    27. AUTOMATED CELL CULTURE
    28. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    29. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
    30. BY PRODUCT TYPE
    31. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. NORTH AMERICA 61
    32. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION
    33. TYPE
    34. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    35. AUTOMATED
    36. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. US 64
    37. AUTOMATED
    38. CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    39. AUTOMATED CELL CULTURE
    40. EQUIPMENT MARKET, BY PRODUCT TYPE
    41. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
    42. BY APPLICATION
      1. CANADA 67
    43. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
    44. BY LAB AUTOMATION TYPE
    45. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT
    46. TYPE
    47. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. LATIN
    48. AMERICA 70
    49. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    50. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    51. AUTOMATED CELL CULTURE
    52. EQUIPMENT MARKET, BY APPLICATION
      1. EUROPE 74
    53. AUTOMATED CELL CULTURE
    54. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    55. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
    56. BY PRODUCT TYPE
    57. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. WESTERN EUROPE 78
    58. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB
    59. AUTOMATION TYPE
    60. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    61. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. GERMANY
    62. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    63. AUTOMATED
    64. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    65. AUTOMATED CELL CULTURE EQUIPMENT
    66. MARKET, BY APPLICATION
      1. UK 85
    67. AUTOMATED CELL CULTURE EQUIPMENT
    68. MARKET, BY LAB AUTOMATION TYPE
    69. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY
    70. PRODUCT TYPE
    71. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    72. FRANCE 88
    73. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    74. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    75. AUTOMATED CELL CULTURE
    76. EQUIPMENT MARKET, BY APPLICATION
      1. ITALY 91
    77. AUTOMATED CELL CULTURE
    78. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    79. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
    80. BY PRODUCT TYPE
    81. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. SPAIN 94
    82. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION
    83. TYPE
    84. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    85. AUTOMATED
    86. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. REST OF WESTERN EUROPE
    87. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    88. AUTOMATED
    89. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    90. AUTOMATED CELL CULTURE EQUIPMENT
    91. MARKET, BY APPLICATION
      1. EASTERN EUROPE 100
    92. AUTOMATED CELL CULTURE
    93. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    94. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
    95. BY PRODUCT TYPE
    96. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. ASIA-PACIFIC 103
    97. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION
    98. TYPE
    99. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    100. AUTOMATED
    101. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. JAPAN 107
    102. AUTOMATED
    103. CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    104. AUTOMATED CELL CULTURE
    105. EQUIPMENT MARKET, BY PRODUCT TYPE
    106. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
    107. BY APPLICATION
      1. CHINA 110
    108. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
    109. BY LAB AUTOMATION TYPE
    110. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT
    111. TYPE
    112. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. AUSTRALIA
    113. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    114. AUTOMATED
    115. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    116. AUTOMATED CELL CULTURE EQUIPMENT
    117. MARKET, BY APPLICATION
      1. INDIA 116
    118. AUTOMATED CELL CULTURE EQUIPMENT
    119. MARKET, BY LAB AUTOMATION TYPE
    120. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY
    121. PRODUCT TYPE
    122. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    123. SOUTH KOREA 119
    124. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION
    125. TYPE
    126. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    127. AUTOMATED
    128. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. REST OF ASIA-PACIFIC 122
    129. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    130. AUTOMATED
    131. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    132. AUTOMATED CELL CULTURE EQUIPMENT
    133. MARKET, BY APPLICATION
      1. MIDDLE EAST & AFRICA 126
    134. AUTOMATED CELL
    135. CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    136. AUTOMATED CELL CULTURE EQUIPMENT
    137. MARKET, BY PRODUCT TYPE
    138. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. MIDDLE EAST 130
    139. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION
    140. TYPE
    141. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    142. AUTOMATED
    143. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. AFRICA 133
    144. AUTOMATED
    145. CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    146. AUTOMATED CELL CULTURE
    147. EQUIPMENT MARKET, BY PRODUCT TYPE
    148. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
    149. BY APPLICATION
    150. COMPETITIVE LANDSCAPE
      1. INTRODUCTION 136
    151. COMPETITIVE ANALYSIS 136
    152. COMPANY PROFILES
      1. TECAN TRADING AG 137
        1. COMPANY OVERVIEW 137
        2. FINANCIAL OVERVIEW 138
        3. PRODUCTS/SERVICES
    153. OFFERED 139
      1. KEY DEVELOPMENTS 140
        1. SWOT ANALYSIS 141
    154. KEY STRATEGIES 141
      1. SIEMENS 142
        1. COMPANY OVERVIEW 142
    155. FINANCIAL OVERVIEW 142
      1. PRODUCTS/SERVICES OFFERED 143
        1. KEY
    156. DEVELOPMENTS 143
      1. SWOT ANALYSIS 144
        1. KEY STRATEGIES 144
      2. HITACHI, LTD 145
        1. COMPANY OVERVIEW 145
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED 146
        4. KEY DEVELOPMENTS 146
        5. SWOT ANALYSIS 147
        6. KEY STRATEGIES 147
      3. THERMO FISHER
    157. SCIENTIFIC INC. 148
      1. COMPANY OVERVIEW 148
        1. FINANCIAL OVERVIEW
        2. PRODUCTS/SERVICES OFFERED 149
        3. KEY DEVELOPMENTS 149
        4. SWOT ANALYSIS 150
        5. KEY STRATEGIES 150
      2. SARTORIUS AG
        1. COMPANY OVERVIEW 151
        2. FINANCIAL OVERVIEW 151
    158. PRODUCTS/SERVICES OFFERED 152
      1. KEY DEVELOPMENTS 152
        1. SWOT
    159. ANALYSIS 153
      1. KEY STRATEGIES 153
      2. HAMILTON COMPANY 154
    160. COMPANY OVERVIEW 154
      1. FINANCIAL OVERVIEW 154
        1. PRODUCTS/SERVICES
    161. OFFERED 154
      1. KEY DEVELOPMENTS 154
        1. SWOT ANALYSIS 155
    162. KEY STRATEGIES 155
      1. BECKMAN COULTER, INC. 156
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW 156
        3. PRODUCTS/SERVICES OFFERED 157
        4. KEY DEVELOPMENTS 157
        5. SWOT ANALYSIS 158
        6. KEY STRATEGIES
      2. F. HOFFMANN-LA ROCHE LTD 159
        1. COMPANY OVERVIEW 159
    163. FINANCIAL OVERVIEW 160
      1. PRODUCTS/SERVICES OFFERED 160
        1. KEY
    164. DEVELOPMENTS 161
      1. SWOT ANALYSIS 161
        1. KEY STRATEGIES 161
      2. PERKINELMER, INC. 162
        1. COMPANY OVERVIEW 162
        2. FINANCIAL
    165. OVERVIEW 162
      1. PRODUCTS/SERVICES OFFERED 163
        1. KEY DEVELOPMENTS
        2. SWOT ANALYSIS 164
        3. KEY STRATEGIES 164
      2. ANTON
    166. PAAR GMBH 165
      1. COMPANY OVERVIEW 165
        1. FINANCIAL OVERVIEW
        2. PRODUCTS/SERVICES OFFERED 165
        3. KEY DEVELOPMENTS 165
        4. SWOT ANALYSIS 166
        5. KEY STRATEGIES 166
    167. APPENDIX
      1. REFERENCES 167
      2. RELATED REPORTS 167
    168. List of Tables
    169. LIST OF ASSUMPTIONS 26
    170. BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 37
    171. CELL CULTURE EQUIPMENT MARKET FOR MODULAR AUTOMATION, BY REGION, 2020–2027
    172. (USD MILLION) 38
    173. WHOLE LAB AUTOMATION, BY REGION, 2020–2027
    174. (USD MILLION) 38
    175. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE, 2020–2027
    176. (USD MILLION) 40
    177. CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 40
    178. CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE, 2020–2027 (USD MILLION)
    179. TYPE, 2020–2027 (USD MILLION) 41
    180. EQUIPMENT MARKET FOR CONSUMABLES, BY REGION, 2020–2027 (USD MILLION) 42
    181. –2027 (USD MILLION) 42
    182. MARKET FOR SOFTWARE, BY REGION, 2020–2027 (USD MILLION) 43
    183. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    184. PRODUCTION, BY REGION, 2020–2027
    185. (USD MILLION) 46
    186. AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR TISSUE ENGINEERING, BY REGION, 2020–2027
    187. (USD MILLION) 47
    188. VACCINE PRODUCTION, BY REGION, 2020–2027 (USD MILLION) 47
    189. AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR DRUG SCREENING AND DEVELOPMENT, BY REGION,
    190. (USD MILLION) 48
    191. EQUIPMENT MARKET FOR GENE THERAPY & REGENERATIVE MEDICINE, BY REGION,
    192. (USD MILLION) 48
    193. STEM CELL THERAPY, BY REGION, 2020–2027 (USD MILLION) 49
    194. AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR TOXICITY TESTING, BY REGION, 2020–2027
    195. (USD MILLION) 49
    196. DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 50
    197. CELL CULTURE EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 52
    198. BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 53
    199. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR RESEARCH AND ACADEMIC INSTITUTES,
    200. BY REGION, 2020–2027 (USD MILLION) 53
    201. CULTURE EQUIPMENT MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION,
    202. –2027 (USD MILLION) 54
    203. EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 57
    204. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027
    205. (USD MILLION) 58
    206. BY PRODUCT TYPE 2020–2027 (USD MILLION) 58
    207. CELL CULTURE EQUIPMENT MARKET FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION)
    208. BY TYPE, 2020–2027 (USD MILLION) 59
    209. CULTURE EQUIPMENT MARKET FOR SOFTWARE, BY TYPE, 2020–2027 (USD MILLION) 59
    210. (USD MILLION) 60
    211. BY END USER 2020–2027 (USD MILLION) 60
    212. CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 61
    213. NORTH AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE,
    214. –2027 (USD MILLION) 61
    215. EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 62
    216. NORTH AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR CONSUMABLES, BY TYPE,
    217. –2027 (USD MILLION) 62
    218. EQUIPMENT MARKET FOR EQUIPMENT, BY TYPE, 2020–2027 (USD MILLION) 62
    219. NORTH AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR SOFTWARE, BY TYPE,
    220. –2027 (USD MILLION) 63
    221. EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 63
    222. NORTH AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027
    223. (USD MILLION) 64
    224. AUTOMATION TYPE, 2020–2027 (USD MILLION) 64
    225. CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 64
    226. US: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR CONSUMABLES, BY TYPE, 2020–2027
    227. (USD MILLION) 65
    228. BY TYPE, 2020–2027 (USD MILLION) 65
    229. EQUIPMENT MARKET FOR SOFTWARE, BY TYPE, 2020–2027 (USD MILLION) 66
    230. US: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD
    231. MILLION) 66
    232. –2027 (USD MILLION) 67
    233. MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 67
    234. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION)
    235. BY TYPE, 2020–2027 (USD MILLION) 68
    236. EQUIPMENT MARKET FOR EQUIPMENT, BY TYPE, 2020–2027 (USD MILLION) 68
    237. CANADA: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR SOFTWARE, BY TYPE, 2020–2027
    238. (USD MILLION) 69
    239. BY APPLICATION 2020–2027 (USD MILLION) 69
    240. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 70
    241. LATIN AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE,
    242. –2027 (USD MILLION) 70
    243. EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 70
    244. LATIN AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR CONSUMABLES, BY TYPE,
    245. –2027 (USD MILLION) 71
    246. EQUIPMENT MARKET FOR EQUIPMENT, BY TYPE, 2020–2027 (USD MILLION) 71
    247. LATIN AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR SOFTWARE, BY TYPE,
    248. –2027 (USD MILLION) 72
    249. EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 72
    250. LATIN AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027
    251. (USD MILLION) 73
    252. BY REGION, 2020–2027 (USD MILLION) 74
    253. CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION)
    254. –2027 (USD MILLION) 75
    255. MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 75
    256. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
    257. (USD MILLION) 76
    258. FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 76
    259. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 77
    260. (USD MILLION) 77
    261. MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 78
    262. CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION)
    263. –2027 (USD MILLION) 79
    264. MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 79
    265. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
    266. (USD MILLION) 80
    267. FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 80
    268. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 81
    269. (USD MILLION) 81
    270. BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 82
    271. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION)
    272. BY TYPE 2020–2027 (USD MILLION) 82
    273. EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 83
    274. GERMANY: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027
    275. (USD MILLION) 83
    276. BY APPLICATION 2020–2027 (USD MILLION) 84
    277. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 84
    278. UK: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027
    279. (USD MILLION) 85
    280. TYPE 2020–2027 (USD MILLION) 85
    281. MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 85
    282. UK: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
    283. (USD MILLION) 86
    284. SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 86
    285. CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 87
    286. UK: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD
    287. MILLION) 87
    288. AUTOMATION TYPE, 2020–2027 (USD MILLION) 88
    289. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 88
    290. TYPE 2020–2027 (USD MILLION) 88
    291. EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 89
    292. FRANCE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027
    293. (USD MILLION) 89
    294. BY APPLICATION 2020–2027 (USD MILLION) 90
    295. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 90
    296. ITALY: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027
    297. (USD MILLION) 91
    298. BY PRODUCT TYPE 2020–2027 (USD MILLION) 91
    299. CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION)
    300. BY TYPE 2020–2027 (USD MILLION) 92
    301. EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 92
    302. ITALY: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027
    303. (USD MILLION) 93
    304. BY END USER 2020–2027 (USD MILLION) 93
    305. CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION)
    306. –2027 (USD MILLION) 94
    307. MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 94
    308. SPAIN: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
    309. (USD MILLION) 95
    310. FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 95
    311. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 96
    312. (USD MILLION) 96
    313. MARKET, BY LAB AUTOMATION TYPE, 2020–2027
    314. (USD MILLION) 97
    315. REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT
    316. TYPE 2020–2027 (USD MILLION) 97
    317. CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE 2020–2027
    318. (USD
    319. MILLION) 97
    320. MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
    321. (USD MILLION) 98
    322. REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE,
    323. BY TYPE 2020–2027
    324. (USD MILLION) 98
    325. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION)
    326. BY END USER 2020–2027 (USD MILLION) 99
    327. CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION)
    328. TYPE 2020–2027 (USD MILLION) 100
    329. CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION)
    330. EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 101
    331. AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD
    332. MILLION) 101
    333. BY APPLICATION 2020–2027 (USD MILLION) 102
    334. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION)
    335. –2027 (USD MILLION) 104
    336. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 104
    337. ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027
    338. (USD MILLION) 104
    339. MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 105
    340. ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
    341. (USD MILLION) 105
    342. MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 106
    343. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION)
    344. USER 2020–2027 (USD MILLION) 107
    345. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 107
    346. JAPAN: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027
    347. (USD MILLION) 107
    348. FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 108
    349. AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
    350. (USD MILLION) 108
    351. FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 109
    352. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 109
    353. (USD MILLION) 110
    354. BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 110
    355. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION)
    356. BY TYPE 2020–2027 (USD MILLION) 111
    357. EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 111
    358. CHINA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027
    359. (USD MILLION) 112
    360. BY APPLICATION 2020–2027 (USD MILLION) 112
    361. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 113
    362. TYPE, 2020–2027 (USD MILLION) 113
    363. CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 113
    364. AUSTRALIA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE
    365. –2027 (USD MILLION) 114
    366. EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 114
    367. AUSTRALIA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027
    368. (USD MILLION) 115
    369. BY APPLICATION 2020–2027 (USD MILLION) 115
    370. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 116
    371. –2027 (USD MILLION) 116
    372. MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 117
    373. AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE 2020–2027
    374. (USD MILLION) 117
    375. FOR EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 117
    376. CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION)
    377. –2027 (USD MILLION) 118
    378. MARKET, BY END USER 2020–2027 (USD MILLION) 119
    379. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027
    380. (USD MILLION) 119
    381. BY PRODUCT TYPE 2020–2027 (USD MILLION) 119
    382. CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION)
    383. BY TYPE 2020–2027 (USD MILLION) 120
    384. CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION)
    385. –2027 (USD MILLION) 121
    386. EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 122
    387. OF ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE,
    388. (USD MILLION) 122
    389. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 122
    390. BY TYPE 2020–2027
    391. (USD MILLION) 123
    392. AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
    393. (USD MILLION) 123
    394. EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 124
    395. REST OF ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    396. –2027 (USD MILLION) 124
    397. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 125
    398. REGION, 2020–2027 (USD MILLION) 126
    399. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027
    400. (USD MILLION) 127
    401. EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 127
    402. MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES,
    403. BY TYPE 2020–2027
    404. (USD MILLION) 127
    405. AFRICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
    406. (USD MILLION) 128
    407. EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027
    408. (USD MILLION) 128
    409. APPLICATION 2020–2027 (USD MILLION) 129
    410. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION)
    411. AUTOMATION TYPE, 2020–2027 (USD MILLION) 130
    412. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 130
    413. BY TYPE 2020–2027 (USD MILLION) 130
    414. CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027 (U

    Automated Cell Culture Equipment Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Automated Cell Culture Equipment Market Research Report - Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027